<DOC>
	<DOC>NCT02724670</DOC>
	<brief_summary>MR (Magnetic Resonance Imaging) - based IGRT (image-guided radiotherapy) for patients with prostate carcinoma.</brief_summary>
	<brief_title>Study of MR-based IGRT for Prostate Cancer</brief_title>
	<detailed_description>Single arm, phase II study, MR (Magnetic Resonance Imaging) - based IGRT (Image-guided radiotherapy) of prostate cancer. Primary endpoint: Grade 2+ GI (gastrointestinal) and genitourinary (GU) toxicity after 2 years.</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>histologically proven prostate cancer indication for curative treatment ECOG performance scale 02 Informed consent contraindications for curative treatment age&lt;18year previous pelvic radiotherapy or prostatic treatment like TURP (transurethral resection of prostate), HIFU (high intensity focused ultrasound) serious comorbidity leading to inability for IGRT (imageguided radiotherapy) contraindications for MRI (Magnetic Resonance Imaging)</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>